MNV
Market News Video
MNV MNV 10 Stocks Crossing Below Book Value
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

We Did The Math IHE Can Go To $222
Thursday, May 18, 8:01 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Revance Therapeutics Breaks Below 200-Day Moving Average - Notable for RVNC
Thursday, June 15, 12:24 PM ET, by Market News Video Staff

In trading on Thursday, shares of Revance Therapeutics Inc (RVNC) crossed below their 200 day ...

MMSC's Holdings Could Mean 16% Gain Potential
Tuesday, June 20, 6:59 AM ET, by Market News Video Staff

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...

Revance Therapeutics Becomes Oversold (RVNC)
Thursday, June 22, 4:06 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

First Week of October 20th Options Trading For Revance Therapeutics (RVNC)
Friday, July 14, 10:48 AM ET, by Market News Video Staff

Investors in Revance Therapeutics Inc (RVNC) saw new options become available this week, for the ...

Snatch Shares of RVNC 12.5% Cheaper Than the CEO Did

By Market News Video Staff, Tuesday, March 12, 11:45 AM ET
Play Video: One Reason For Insiders to Buy


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Email EnvelopeFree Email Alerts By Stock:
Get Dividend Alerts
Get SEC Filing Alerts

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 6, Revance Therapeutics Inc's CEO, Mark J. Foley, invested $209,400.00 into 30,000 shares of RVNC, for a cost per share of $6.98. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.

In trading on Tuesday, bargain hunters could buy shares of Revance Therapeutics Inc (NASDAQ:RVNC) and achieve a cost basis 12.5% cheaper than Foley, with shares changing hands as low as $6.11 per share. Revance Therapeutics Inc shares are currently trading up about 4.2% on the day. The chart below shows the one year performance of RVNC shares, versus its 200 day moving average:

Revance Therapeutics Inc Chart

Looking at the chart above, RVNC's low point in its 52 week range is $5 per share, with $37.98 as the 52 week high point — that compares with a last trade of $5.96. By comparison, below is a table showing the prices at which RVNC insider buying was recorded over the last six months:

Purchased Insider Title Shares Price/Share Value
03/06/2024 Mark J. Foley CEO 30,000 $6.98 $209,400.00

Free Report: Top 8%+ Dividends (paid monthly)


This Article's Word Cloud:   Back   Bargain   Bargains   Cheaper   Dividends   Foley   Free   Insider   Insiders   Looking   March   Mark   Price   Purchased   RVNC   Report   Revance   Share   Shares   Start   Street   Than   Therapeutics   There   Title   Tuesday   Value   Wall   about   above   achieve   attention   below   buying   chart   cost   hunters   insider   last   only   point   reason   share   shares   stock   that   their   trading   week   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy
MNV
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Snatch Shares of RVNC 12.5% Cheaper Than the CEO Did | Market News Video | Copyright © 2008 - 2024, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.

X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.